版本:
中国

BRIEF-Ligand enters commercial license and supply agreements with Marinus Pharmaceuticals for captisol-enabled Ganaxolone

April 5 Ligand Pharmaceuticals Inc

* Ligand enters commercial license and supply agreements with Marinus Pharmaceuticals for captisol-enabled Ganaxolone

* LIGAND PHARMACEUTICALS -Marinus is preparing to initiate clinical trials with captisol-enabled Ganaxolone IV in patients with PPD and Status Epilepticus Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐